Evidence map›Paper›PMID 42465101›Full record

ArticleFrontiers in medicine2026

Subtype-specific sonographic signatures and clinicopathological features of metaplastic breast cancer: a 50-case cohort study.

Boxiong Wei, Zijing Fu, Yuhong Shao, Xiuming Sun, Luzeng Chen

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Boxiong WeiDepartment of Ultrasound, Peking University First Hospital, Beijing, China.
Zijing FuDepartment of Ultrasound, Peking University First Hospital, Beijing, China.
Yuhong ShaoDepartment of Ultrasound, Peking University First Hospital, Beijing, China.
Xiuming SunDepartment of Ultrasound, Peking University First Hospital, Beijing, China.
Luzeng ChenDepartment of Ultrasound, Peking University First Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metaplastic breast cancer (MBC) is a rare, aggressive malignancy with profound histological heterogeneity. This study aimed to describe the subtype-specific sonographic signatures and baseline clinicopathological features of MBC based on the World Health Organization classification. Methods: This exploratory single-center retrospective cohort study included 50 women with histologically confirmed MBC (15 spindle cell, 12 squamous cell, and 23 mixed type) treated between January 2010 and January 2026. Preoperative ultrasound features, evaluated via BI-RADS criteria, and baseline clinicopathological parameters were compared across subtypes. Results: The spindle cell subtype frequently presented with a pseudo-benign sonographic phenotype, characterized by circumscribed margins (60.0%) and oval or round shape (46.7%), along with significantly smaller tumor dimensions (median 3.1 cm; Conclusion: MBC demonstrates significant subtype-specific heterogeneity. The pseudo-benign sonographic appearance of the spindle cell subtype represents a major diagnostic pitfall, supporting prompt biopsy for rapidly enlarging lesions. The observed size-node pattern should be interpreted as descriptive and hypothesis-generating, because nodal events were limited and long-term survival, recurrence, and distant metastasis data were unavailable. Recognizing these distinct patterns may facilitate accurate diagnosis and timely multidisciplinary management.

Indexed as

BI-RADShistological subtypeslymph node metastasismetaplastic breast cancerultrasonography

Identifiers

PMID42465101
PMCPMC13373711

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.